bluebird bio, Inc. (BLUE)

1 member of Congress has disclosed 4 trades in bluebird bio, Inc. (BLUE) via STOCK Act filings. The most recent disclosure was a sale by Lois Frankel on 11 December 2020. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for BLUE
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for BLUE

4 transactions
Compliance: 100%
Lois Frankel11 Dec 202028 Dec 2020SaleStock$1,001 - $15,000N/A
Lois Frankel10 Dec 202028 Dec 2020SaleStock$1,001 - $15,000N/A
Lois Frankel15 Jul 202024 Jul 2020PurchaseStock$1,001 - $15,000N/A
Lois Frankel27 Apr 202028 May 2020PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$48.67M

Volume

1.25M

Beta

0.36

P/E Ratio

-0.24

Fundamentals

EPS

$-20.59

Div. Yield

-

Open

$4.97

Day Range

$4.97 – $4.97

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Andrew Obenshain
IPO Date
2013-06-19
Website
www.genetixbiotx.com

bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery, development, and commercialization of innovative gene therapies. These pioneering treatments are aimed at debilitating genetic conditions. Among its leading investigationa...

Earnings

Recent Quarters

Q1 202612 May
EPS-
Q3 202512 Nov
EPS-
Q1 202514 May
EPS$-3.74
Miss 13.7%
Q4 202427 Mar
EPS$-5.60
Beat 8.9%
Q3 202414 Nov
EPS$-6.20
Beat 14.8%
Q2 202414 Aug
EPS$-8.40
Miss 15.3%
Q1 20249 May
EPS$-7.60
Miss 1451.0%
Q4 202326 Mar
EPS$-11.80
Miss 1687.9%
Q3 20237 Nov
EPS$-13.20
Miss 0.5%
Q2 20238 Aug
EPS$-13.40
Miss 0.2%
Q1 20239 May
EPS$4.20
Beat 156.8%
Q4 202229 Mar
EPS$7.60
Beat 1788.9%
Q3 20227 Nov
EPS$-0.94
Beat 15.9%
Q2 20224 Aug
EPS$-1.27
Beat 2.1%
Q1 20229 May
EPS$-1.66
Miss 14.9%
Q4 20214 Mar
EPS$-2.14
Beat 94.1%
Q3 20215 Nov
EPS$-3.16
Beat 94.2%
Q2 20219 Aug
EPS$-3.58
Beat 94.5%
Q1 20215 May
EPS$-3.07
Beat 95.0%
Q4 202023 Feb
EPS$-3.01
Beat 95.0%
Q3 20204 Nov
EPS$-2.94
Beat 95.2%
Q2 20205 Aug
EPS$-0.36
Beat 99.1%
Q1 202011 May
EPS$-3.64
Beat 95.4%
Q4 201918 Feb
EPS$-4.04
Beat 94.7%
Q3 201931 Oct
EPS$-3.73
Beat 94.7%
Q2 20191 Aug
EPS$-3.55
Beat 94.1%
Q1 20192 May
EPS$-2.99
Beat 94.7%
Q4 201821 Feb
EPS$-2.72
Beat 95.2%
Q3 20181 Nov
EPS$-2.73
Beat 95.3%
Q2 20182 Aug
EPS$-2.91
Beat 93.7%
Q1 20182 May
EPS$-2.31
Beat 94.2%
Q4 201721 Feb
EPS$-2.52
Beat 92.3%
Q3 20171 Nov
EPS$-1.73
Miss 1.2%
Q2 20172 Aug
EPS$-1.73
Beat 94.7%
Q1 20173 May
EPS$-1.68
Beat 95.1%
Q4 201622 Feb
EPS$-1.88
Miss 1.1%
Q3 20162 Nov
EPS$-2.07
Beat 93.4%
Q2 20163 Aug
EPS$-1.59
Beat 94.4%
Q1 20164 May
EPS$-1.52
Beat 93.6%
Q4 201524 Feb
EPS$-1.29
Beat 94.3%
Q3 20154 Nov
EPS$-1.18
Miss 25.5%
Q2 20156 Aug
EPS$-1.57
Beat 90.8%
Q1 20156 May
EPS$-0.76
Miss 24.6%
Q4 201425 Feb
EPS$-0.67
Beat 94.6%
Q3 201412 Nov
EPS$-0.61
Miss 22.0%
Q2 201412 Aug
EPS$-0.54
Beat 94.0%
Q1 201413 May
EPS$-0.44
Miss 22.2%
Q4 20135 Mar
EPS$-0.34
Beat 94.3%
Q3 201314 Nov
EPS$-0.26
Beat 93.5%
Q2 201314 Aug
EPS$-2.13
Miss 508.6%
Q4 201231 Mar
EPS$-19.95
Miss 1446.6%
Q3 201231 Dec
EPS$-0.39
Q2 201230 Sept
EPS$-0.22
Q1 201230 Jun
EPS$-0.20
Q4 201131 Mar
EPS$-0.22

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

13 Dec 2024Reverse Split
Ratio1:20
5 Nov 2021Stock Split
Ratio193:125

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BLUE

Which members of Congress have traded BLUE?
1 member of Congress has disclosed 4 trade in bluebird bio, Inc. (BLUE) under the STOCK Act: Lois Frankel.
When was BLUE most recently disclosed by Congress?
The most recent BLUE disclosure was a sale by Lois Frankel on 11 December 2020.
What is the total disclosed congressional trading volume for BLUE?
Members of Congress have disclosed approximately $16K in BLUE purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BLUE?
This BLUE page updates as soon as new STOCK Act disclosures are filed for bluebird bio, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.